-
LiqTech receives Nasdaq deficiency notice for bid price below $1.00
Received Nasdaq notice on July 21, 2026 for failing minimum bid price rule (closing bid <$1.00 for 30 consecutive business days).
-
LiqTech closes $20M public offering of 20M shares at $1.00; proceeds to retire $4.1M debt
Offered 20,000,000 shares at $1.00/share; underwriter has 45-day option for 3,000,000 additional shares.
-
LiqTech to convert $3M of $6M debt to equity, pay $3M cash in restructuring
LiqTech enters Debt Cancellation Agreement to extinguish $6M senior notes; $3M converted to common stock at offering price.
-
LiqTech International issues $1.1M in 9.09% discount promissory notes to Bleichroeder and Lytton affiliates
Sold $1.1M aggregate principal of 9.09% original discount notes for $1M to affiliates of Bleichroeder L.P. and Laurence W. Lytton.
-
LiqTech raises up to $10M via equity and warrant offering; first tranche closed for $1.2M
Issued 3.63M shares, 1.37M pre-funded warrants, and 5M warrants at $2.00 per unit.
-
LiqTech signs exclusive 3-year distribution deal with NESR for produced water treatment in 15 countries
Exclusive 3-year agreement for LiqTech's CFUF systems in 15 Middle East, Africa, Asia countries for produced water re-injection.
-
LiqTech warns $3-4M orders at risk; CEO Fei Chen starts Sept 12
Fei Chen began as CEO on Sept 12, 2022; Alex Buehler stepped down as interim CEO but remains on board.
-
LiqTech appoints Fei Chen as CEO effective Nov 1, 2022; interim CEO Buehler returns to board
Fei Chen named President & CEO effective on or before Nov 1, 2022; also joins board on start date.
-
LiqTech receives Nasdaq notice for non-compliance with $1 minimum bid price
Nasdaq notice dated June 24, 2022 for 30 consecutive trading days below $1.00 closing bid.
-
LiqTech raises ~$23M in public offering of common stock and pre-funded warrants
Company sells 15,635,850 shares at $0.50 and pre-funded warrants for 30,425,000 shares at $0.499.
-
LiqTech CEO Sune Mathiesen takes medical leave; board member Alex Buehler appointed Interim CEO
CEO Sune Mathiesen began medical leave of absence effective March 17, 2022.
-
LiqTech appoints Simon Stadil as CFO effective Dec 1, 2021; predecessor Toftegaard moves to project role
Simon Stadil named CFO; previously VP Global Finance at Welltec (~$250M revenue).